This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA

Yogapriya Murugesan
Scientist I at Biogen
Speaker

Profile

Yogapriya works as a Scientist I at Biogen, Inc. in the Drug product group of Biologics and Advanced therapy Medicinal Products department. She has over 10 years of experience in Research and Product Development of Biologics comprising of monoclonal antibodies and AAV drug products. She has managed multiple biologics programs at different stages of development. Her current role focuses more on the developability assessment of biologics (mAbs and AAV) to help in candidate selection process for R2D transitions and end-to-end drug product development of biologics drug product candidates from R2D to FIH with respect to formulation lockdown, process development, and container closure selection. In the past, she has worked as a biochemist in discovery programs focused on purification, biochemical, and biophysical characterization of monoclonal antibody therapeutics in Biologics Drug discovery.

Agenda Sessions

  • Comparing the Outlook of Developability Assessment of Monoclonal Antibodies to AAV Therapeutics for Successful Lead Candidate Selection from Discovery to Development

    3:00pm
  • Formulation and Fill Finish Challenges and Round Up

    4:00pm